Search

Search Constraints

You searched for: Author/Creator Viniou, Nora-Athina

Search Results

1. A case report of a fulminant Aeromonas hydrophila soft tissue infection in a patient with acute lymphoblastic leukemia harboring a rare translocation. (3rd July 2022)

2. A case report of a very late response to 5-azacytidine in a patient with lower risk myelodysplastic syndrome: Time to update treatment guidelines for lower risk patients. Issue 17 (April 2018)

4. A clinical audit of nutritional screening and support of hospitalized patients with hematologic diseases. (April 2018)

5. An Adult Patient with Systemic Mastocytosis and B-Acute Lymphoblastic Leukemia. (5th November 2014)

6. Body mass index and relative dose intensity does not affect the response and outcome of high-risk MDS patients treated with azacytidine. Results from the Hellenic (Greek) MDS study group. (August 2018)

7. Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-Azacytidine. Issue 3 (23rd February 2022)

8. Clinical considerations about the coexistence of melanoma and chronic lymphocytic leukemia in the era of targeted therapies, triggered by rare clinical scenarios. A case series and review of the literature. (October 2020)

9. Correlation of Fc-γ RIIA polymorphisms with latent Epstein–Barr virus infection and latent membrane protein 1 expression in patients with low grade B-cell lymphomas. Issue 9 (September 2013)

10. Effectiveness of 5-Azacytidine in older patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia: A retrospective analysis of the Hellenic (Greek) MDS Study Group. Issue 1 (January 2020)